NCT06935513Recruiting
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
Source: ClinicalTrials.gov · Last updated 30 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- First submitted
- 30 Mar 2025
- Start date
- 20 Apr 2025
- Primary completion date
- 20 Oct 2025
- Lead sponsor
- Affiliated Hospital of Nantong University
- Diseases
- Obesity, Stroke, Atrial fibrillation, High blood pressure
- NCT number
- NCT06935513
What you commit to
- Study type: Interventional
- Planned participants: 300
- From 20 Apr 2025 to the primary completion date, 20 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosed with malignancies;
- Diagnosed with psychiatric disorders;
- Diagnosed with cognitive impairment;
Other
- Unable to operate smart wearable devices.
Who the study is looking for
- Diagnosed with hypertension;
- Diagnosed with diabetes;
- Diagnosed with atrial fibrillation;
- Smoking subjects;
- Physical inactive subjects；
- Obesity and overweight subjects;
- Must be able to use smart wearable devices.
Age in the registry: 30 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Affiliated Hospital of Nantong University Coordinator of this site? Confirm its status | Nantong | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.